Pricing Policies Mean Cheap Drugs Dominate Turkish Market
This article was originally published in PharmAsia News
The Turkish government’s unrelenting policies to curb prices in the local pharmaceutical industry are having a big impact on the shape of the market. While demand for the cheapest products is strengthening, the market share of drugs with a higher price tag is becoming marginalized. Meanwhile, the industry is still unhappy with changes to the fixed Euro exchange rate.